[Chlorprothixene-induced central anticholinergic syndrome (author' transl)].
A case is reported in which unconsciousness and apnoea extending into the postoperative period were noted as a central anticholinergic syndrome caused by chlorprothixene. This compound was employed for preanaesthetic medication in usual clinical dosage. Physostigmine salicylate was effective in reversing the toxic side effects of chlorprothixene - an occasionally active central anticholinergic agent.
D001049:Apnea / Q000139:chemically induced*; D002648:Child; D002749:Chlorprothixene / Q000009:adverse effects*; D005260:Female; D006801:Humans; D010830:Physostigmine / Q000627:therapeutic use; D011184:Postoperative Period; D011292:Premedication; D013577:Syndrome; D014474:Unconsciousness / Q000139:chemically induced*
D002749:Chlorprothixene; D010830:Physostigmine
Chlorprothixen-induziertes zentral anticholinerges Syndrom.